• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Poll: Preferred treatment plans for mild-stage POAG

Poll

Weigh in on our poll!

If diagnosed with mild-stage POAG, what would be your preferred treatment plan?

A. Initiate medical therapy with a topical glaucoma medication.
B. Have selective laser trabeculoplasty (SLT)
C. Have a minimally invasive glaucoma surgery (MIGS)
Related Videos
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Nate Lighthizer, OD, speaks on lasers in optometry at AAOpt 2023
Gleb Sukhovolskiy, OD
Justin Schweitzer, OD, FAAO, and Selina McGee, OD, FAAO, Dipl ABO, discuss their AAOpt presentation on the intersection of dry eye and glaucoma
Monique Barbour, MD
Justin Schweitzer and Nate Lighthizer discuss surgical interventions in glaucoma at AOA 2023.
Related Content
array of fast food, sugary sweets, pizza Image credit: ©beats_ - adobe.stock.com

Study evaluates the potential correlation of ultra-processed food consumption and increased glaucoma incidence

April 16th 2024
Article
Optometry Times You and Eye

You and Eye: What optometrists need to know about low vision

March 13th 2024
Podcast
Dollar bills in jar Image credit: ©peshkova - adobe.stock.com

ViaLase announces closure of financing series with $40 million for laser advancement

April 2nd 2024
Article
Podcast: Celebrate World Glaucoma Week March 7-13, 2021

Podcast: Celebrate World Glaucoma Week March 7-13, 2021

February 27th 2021
Podcast
drug-eluting contact lens on finger following positive results of phase 2b trial for open angle glaucoma - Image credit: Adobe Stock /Aghavni

Phase 2b trial complete for OAG drug-eluting contact lens from MediPrint Ophthalmics

March 11th 2024
Article
Eye care provider holds eye diagram up to patient Image credit: ©auremar - adobe.stock.com

Real-world efficacy and safety of switching to Latanoprostene Bunod 0.024% in OAG and OHT patients

March 5th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.